DE:1I4 Stock Latest News
Company AnnouncementsHeraMED Wins People’s Choice Award at Garmin Health Awards15h ago
Company AnnouncementsHeraMED Secures First Major U.S. SaaS Rollout With Lee Health3d ago
Company AnnouncementsHeraMED Secures Full-Scale Digital Maternity Rollout with US Health System Lee Health1M ago
Company AnnouncementsHeraMED Shares Halted Ahead of Material Commercial Deployment News1M ago
Company AnnouncementsHeraMED Issues 3.3 Million Unquoted Performance Rights Under Incentive Plan2M ago
Company AnnouncementsHeraMED Narrows Half-Year Loss as Revenue Slumps but Asset Backing Improves2M agoCompany AnnouncementsHeraMED Advances U.S. Digital Pregnancy Rollout with Lee Health and Philips3M ago
Company AnnouncementsHeraMED Director’s Options Lapse, Slightly Reducing Future Equity Exposure3M ago
Company AnnouncementsHeraMED Options Expire, Simplifying ASX-Listed Medtech’s Capital Structure3M ago
Company AnnouncementsHeraMED Pilot with Lee Health Validates Digital-First Prenatal Care Model3M ago- Company AnnouncementsHeraMED Issues 15 Million Unquoted Options in Capital Management Move4M ago
Company AnnouncementsHeraMED Issues 4 Million Unquoted Options in New Equity Class4M ago- Company AnnouncementsHeraMED Adds 2.5 Million Shares to ASX Quotation5M ago
Company AnnouncementsHeraMED Accelerates U.S. Push as Philips Partnership and Lee Health Pilot Gain Traction6M ago- Company AnnouncementsHeraMED Director Timothy Chapman Granted 2.5 Million Performance Rights6M ago
- Company AnnouncementsHeraMED Issues 3 Million Unquoted Options Under Employee Scheme6M ago
Company AnnouncementsHeraMED Issues 4 Million Unquoted Performance Rights Under Staff Incentive Plan6M agoCompany AnnouncementsHeraMED Issues 3 Million Unquoted Options Under Employee Incentive Scheme6M ago